Prescribing Policy Statements

Folder Prescribing Policy Statements

Documents

Toggle Title Date
pdf Debrisoft February 2015 ( pdf, 221 KB ) (2647 downloads) Popular
pdf Erectile Dysfunction Policy January 2019 ( pdf, 345 KB ) (7849 downloads) Popular
pdf Glucosamine February 2015 ( pdf, 370 KB ) (3654 downloads) Popular
pdf Ketamine February 2015 ( pdf, 228 KB ) (2945 downloads) Popular
pdf Omega 3 fatty acids February 2015 ( pdf, 361 KB ) (4440 downloads) Popular
pdf Sodium Hyaluronate February 2015 ( pdf, 336 KB ) (3616 downloads) Popular
pdf Sodium oxybate February 2015 ( pdf, 332 KB ) (3192 downloads) Popular
pdf Vibropulse February 2015 ( pdf, 337 KB ) (2804 downloads) Popular
pdf Nicotine Replacement Therapy April 2015 ( pdf, 228 KB ) (2185 downloads) Popular
pdf Resperate Prescribing Policy - August 2015 ( pdf, 301 KB ) (4656 downloads) Popular
pdf Gluten free prescribing restriction policy - March 2018 ( pdf, 274 KB ) (4310 downloads) Popular
pdf Co-amoxiclav: long term use in lower back pain prescribing policy Feb 2016 ( pdf, 237 KB ) (3367 downloads) Popular
pdf Liothyronine and unlicensed dried thyroid extract MSEMOC position statement October 2020 ( pdf, 149 KB ) (6525 downloads) Popular
pdf Infantile colic June 2016 ( pdf, 364 KB ) (4846 downloads) Popular
pdf Rubefacients (excluding topical NSAIDs) June 2016 ( pdf, 346 KB ) (4128 downloads) Popular
pdf Dental preparations MSEMOC position statement October 2020 ( pdf, 143 KB ) (4472 downloads) Popular
pdf Oxycodone/naloxone combination product MSEMOC position statement October 2020 ( pdf, 141 KB ) (3515 downloads) Popular
pdf Naltrexone and Bupropion (Mysimba®) in obesity - Jan 2016 ( pdf, 224 KB ) (1723 downloads) Popular
pdf Multivitamins and minerals - Mid Essex prescribing policy May 2019 (updated March 2021) ( pdf, 294 KB ) (4391 downloads) Popular
pdf Pregabalin prescribing policy statement June 2016 ( pdf, 261 KB ) (2682 downloads) Popular